Understanding the Chemical Synthesis Pathway of Tert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate (CAS 571189-16-7)
For professionals in the chemical and pharmaceutical industries, a thorough understanding of synthesis pathways is vital. NINGBO INNO PHARMCHEM CO.,LTD. provides detailed insights into the synthesis of key compounds, including Tert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate (CAS 571189-16-7), a critical intermediate.
The synthesis of this complex molecule typically involves the reaction of 1-(6-nitropyridin-3-yl)piperazine with di-tert-butyl dicarbonate. This reaction is commonly carried out in an organic solvent such as tetrahydrofuran (THF), employing a base like triethylamine to facilitate the process. A catalyst, often 4-dimethylaminopyridine, is used to enhance the reaction rate and yield. The meticulous control of reaction temperature, often kept below 27°C during the addition phase and then refluxed, is crucial for optimizing the output and purity of the final product. NINGBO INNO PHARMCHEM CO.,LTD. employs these precise techniques to ensure the high quality of their Tert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate.
This compound is highly valued as a pharmaceutical intermediate and an organic synthesis building block. Its specific structure makes it an indispensable component in the production of pharmaceuticals like Palbociclib. By providing this essential CAS 571189-16-7 pharmaceutical intermediate, NINGBO INNO PHARMCHEM CO.,LTD. supports researchers and manufacturers in their efforts to develop innovative solutions. The company's commitment to quality and clear documentation of synthesis processes makes them a trusted partner for chemical professionals requiring reliable materials for their research and production needs.
Perspectives & Insights
Molecule Vision 7
“This compound is highly valued as a pharmaceutical intermediate and an organic synthesis building block.”
Alpha Origin 24
“Its specific structure makes it an indispensable component in the production of pharmaceuticals like Palbociclib.”
Future Analyst X
“By providing this essential CAS 571189-16-7 pharmaceutical intermediate, NINGBO INNO PHARMCHEM CO.”